Inventor
MINGOZZI FEDERICO
FR17 patents
⚠️ This page may combine multiple inventors who share the name “MINGOZZI FEDERICO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENETHON
8 patentsUS11421211B2Aug 23, 2022
Acid-alpha glucosidase variants and uses thereof
GENETHON4 citations70
US11339406B2May 24, 2022
Acid-alpha glucosidase variants and uses thereof
GENETHON3 citations70
US10471132B2Nov 12, 2019
Treatment of hyperbilirubinemia
GENETHON3 citations61
US12305187B2May 20, 2025
Acid-alpha glucosidase variants and uses thereof
GENETHON0 citations59
US12171843B2Dec 24, 2024
Hybrid regulatory elements
GENETHON0 citations58
US12037362B2Jul 16, 2024
Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
GENETHON1 citations55
US11541131B2Jan 3, 2023
Treatment of glycogen storage disease III
GENETHON0 citations54
US11376321B2Jul 5, 2022
Method for removing anti-AAV antibodies from a blood-derived composition
GENETHON0 citations51
CHILDRENS HOSPITAL PHILADELPHIA
6 patentsUS9909142B2Mar 6, 2018
Composition and methods for highly efficient gene transfer using AAV capsid variants
CHILDRENS HOSPITAL PHILADELPHIA24 citations91
US11939590B1Mar 26, 2024
AAV vector compositions and methods for gene transfer to cells, organs and tissues
CHILDRENS HOSPITAL PHILADELPHIA0 citations61
US11279950B2Mar 22, 2022
Composition and methods for highly efficient gene transfer using AAV capsid variants
CHILDRENS HOSPITAL PHILADELPHIA0 citations59
US11559589B2Jan 24, 2023
Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
CHILDRENS HOSPITAL PHILADELPHIA0 citations57
US11408899B2Aug 9, 2022
AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies
CHILDRENS HOSPITAL PHILADELPHIA0 citations51
US10640785B2May 5, 2020
Virus vectors for highly efficient transgene delivery
CHILDRENS HOSPITAL PHILADELPHIA0 citations47